Thus, XPO1 inhibition provides a novel and promising anticancer strategy able to prevent inactivation of tumor suppressors and the translation of several key mRNAs and proteins by preventing their export and restricting them to the nucleus. This evidence concerns the gene XPO1 and neoplasm.